Organovo Holdings, Inc. (ONVO)
-OTC Markets 4.27 
0.24(5.96%) May 17, 3:59PM EDT
| Prev Close: | 4.03 |
|---|
| Open: | 4.01 |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 4.00 - 4.45 |
|---|
| 52wk Range: | 1.49 - 10.90 |
|---|
| Volume: | 449,618 |
|---|
| Avg Vol (3m): | 531,787 |
|---|
| Market Cap: | 265.75M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -1.01 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Organovo: Get Rich Or Die Tryin'at Seeking Alpha(Wed, May 15)
- The 4 Healthcare Companies Investors Should Be Watchingat Seeking Alpha(Tue, May 14)
- 2 Medical Device Companies With Revolutionary Platformsat Seeking Alpha(Mon, May 13)
- Why Royalty And Milestone Partnership Dynamics Imply Trovagene Could Tripleat Seeking Alpha(Fri, May 3)
- 3 Biotechs Flying Under The Radarat Seeking Alpha(Tue, Apr 30)
- Organovo to Present at the 12th Annual Needham Healthcare ConferencePR Newswire(Thu, Apr 25)
- Organovo Describes First Fully Cellular 3D Bioprinted Liver TissuePR Newswire(Mon, Apr 22)
- Why An Uplisting Could Lead To A Surge In Demand For InVivoat Seeking Alpha(Wed, Apr 17)
- The 3-D Printers: How Do the Players Stack Up?at Motley Fool(Wed, Apr 17)
- Organovo to Describe 3D Liver Assay at Experimental Biology ConferencePR Newswire(Wed, Apr 10)
- Tech And Healthcare: Eye Catching Themes Of Early Aprilat Seeking Alpha(Tue, Apr 9)
- Organovo, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.comPR Newswire(Mon, Apr 8)
- ORGANOVO HOLDINGS, INC. Files SEC form 8-K, Regulation FD DisclosureEDGAR Online(Wed, Apr 3)
- Organovo Holdings, Inc. Announces Change of Fiscal YearPR Newswire(Wed, Apr 3)
- ORGANOVO HOLDINGS, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, FinanciaEDGAR Online(Tue, Apr 2)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 209.54 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(0-00-31)
: | N/A |
|---|
| Quarterly EPS Est
(0-00-31)
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Organovo Holdings, Inc. develops three-dimensional (3D) bioprinting technology for creating functional human tissues on demand for research and medical applications.
View More